EyePoint (EYPT) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precipio (PRPO) has outperformed EyePoint (EYPT) over the past year, gaining 26.4% versus a loss of 75.1%. Over five years, PRPO leads with a -54.7% price change compared with -69.8% for EYPT. EyePoint is the larger company by market cap ($288.4 million vs $42.0 million), about 6.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYPT | PRPO |
|---|---|---|
| Share price | $3.44 | $23.47 |
| Market cap | $288.41M | $42.02M |
| 1-day change | -0.58% | +1.21% |
| YTD return | -81.06% | +0.91% |
| 1-year return | -75.07% | +26.38% |
| 5-year return | -69.76% | -54.71% |
| Forward P/E | — | 60.18 |
| EPS (TTM) | $-3.75 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.11 | $33.63 |
| 52-week low | $3.05 | $16.40 |
| Distance from 52-week high | -82.00% | -30.21% |
| Analyst consensus | none | — |
| Avg. price target upside | +653.20% | — |
| Average volume | 3.96M | 127.60K |
| Shares outstanding | 83.84M | 1.79M |
| Employees | 214 | 61 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EyePoint is about 6.9 times larger than Precipio by market value ($288.41M vs $42.02M).
- PRPO has outperformed EYPT by 101.4 percentage points over the past year.
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 61 employees
EYPT vs PRPO FAQ
Which is bigger, EyePoint or Precipio?
EyePoint (EYPT) is larger, with a market capitalization of $288.41M compared with $42.02M for Precipio (PRPO).
Which stock has performed better over the past year, EYPT or PRPO?
PRPO returned +26.38% over the past 12 months, compared with -75.07% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Are EyePoint and Precipio in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.